ABVC

ABVC

ABVC Biopharma Inc

ABVC Biopharma develops plant-derived drugs and medical devices to address unmet medical needs in the U.S. Its pipeline includes treatments for cancers, depressive disorders, ADHD, and retinal issues, primarily in clinical trial phases.

โš•๏ธ Healthcare NASDAQ Listed 2017 $ USD
$1,000 invested 20 years ago โ†’$0today

Score Overview

1 Year
Score
Net Growth-19.15%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-100.00%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score4.1
Net Growth26.61%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth-100.00%
Rev Trend60%
Revenue Consistencyโ€”
All Time
Score
Net Growth-122.08%
Net Trend33%
Net Income Consistency
Rev Growth-100.00%
Rev Trend56%
Revenue Consistency

See the full market ranking โ†’

ABVC Biopharma Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 483.05K to $ 795.95K and net income went from -$ 9M to -$ 7M. Revenue increased in 3 of those 5 years; net income in 2.

Across ABVC Biopharma Inc's full reported history, from 2017 to 2025, revenue grew from $ 3.2K to $ 795.95K and net income went from -$ 4M to -$ 7M. Revenue increased in 56% of the years measured; net income in 33%.

ABVC Biopharma Inc currently holds a 5-year HDB Score of 4.1 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-13
$ 0.96โ€”
1 Year2025-08-13
$ 2.97-67.70%
5 Years2021-08-13
$ 23.20-95.86%
10 Years2016-08-12
$ 360.00-99.73%
20 Years2006-08-11
$ 1000K-100.00%
All Time2017-10-11
$ 360.00-99.73%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 0.00-$ 9M$ 202.51K
2025$ 795.95K-$ 7M$ 745.83K
2024$ 509.59K-$ 4M$ 928.55K
2023$ 152.43K-$ 7M$ 796.09K
2022$ 969.78K-$ 16M$ 1M
2021$ 355.8K-$ 12M$ 5M
2020$ 483.05K-$ 9M$ 5M
2019$ 701.72K-$ 3M$ 144.29K
2018$ 6.96K-$ 5M$ 40.04K
IPO2017$ 3.2K-$ 4M$ 256.93K

Explore beyond ABVC

You're looking at ABVC Biopharma Inc. Members apply the same fundamental framework across all 3,859 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies